Of the 167 million individuals with employer-sponsored insurance coverage in 2022, 3.4 million used not less than one of many first 10 medication recognized for Medicare value negotiations, a brand new evaluation discovered. Probably the most generally used drug for these with employer-sponsored medical health insurance was Jardiance, a drug used to deal with diabetes and coronary heart failure, taken by greater than 911,000 enrollees.

The evaluation makes use of Merative MarketScan 2022 business claims to estimate the variety of enrollees within the employer-sponsored insurance coverage market who use a number of of the ten medication chosen for Medicare Half D value negotiations.

The total evaluation and different well being care value knowledge can be found on the Peterson-KFF Well being System Tracker, an internet data heart designed to observe and assess the efficiency of the U.S. well being care system.